IBSA Pharma
0795.266.574 · rovalta.com · 23/09/2026
IBSA Pharma
Overview
What does IBSA Pharma do?
IBSA Pharma is a Private limited company incorporated in 2022. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Bruxelles. It employs on average 2,0 ETP workers (FTE).
1000 Bruxelles · BruxellesSee on map
Joint committees (1)
- 200
Trend over 3 financial years
| 2025 | 2024 | 2023 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Gross margin | 252,6 k € | -20.6% | 318 k € | +217% | 100,2 k € |
| EBITDA | 18,7 k € | -10.7% | 21 k € | +150% | 8,4 k € |
| Operating result | 18,7 k € | -10.7% | 21 k € | +150% | 8,4 k € |
| Net result | 1,3 k € | -78.8% | 6,1 k € | +151% | 2,4 k € |
| Balance sheet | |||||
| Equity | 34,9 k € | +3.9% | 33,6 k € | +22.3% | 27,4 k € |
| Total assets | 71,7 k € | -21.0% | 90,8 k € | +4.0% | 87,3 k € |
| Cash | 20,6 k € | -34.9% | 31,7 k € | +107% | 15,3 k € |
| Debts | 36,9 k € | -35.6% | 57,2 k € | -4.4% | 59,9 k € |
| Other | |||||
| Workforce | 2,0 ETP | 0.0% | 2,0 ETP | – | |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 3 active · 4 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
ADVOLIS BELGIUM● Active | 1016.646.607 |
AFH BELGIUM● Active | 0828.719.203 |
Ammonia Europe● Active | 0805.797.608 |
| 0811.841.795 | |
ARXIS● Active | 0875.644.338 |
ASAP● Active | 0476.883.969 |
| 0768.694.217 | |
Awbury Belgium● Active | 1014.429.562 |
Burson● Active | 0425.042.518 |
| 0864.172.901 | |
| 0778.768.557 | |
Dest International● Active | 0804.759.510 |
Devyser● Active | 0783.330.626 |
DIGITAL MUSIC EUROPE● Active | 0760.299.361 |
DOCTENA AFSPRAKEN● Active | 0462.846.881 |
DOCTENA Belgium● Active | 0553.796.358 |
Dystonia Europe● Active | 0872.308.924 |
Eestermans Associates● Active | 0647.833.306 |
| 0894.730.077 | |
| 0425.678.758 |
Financials
Full financial information
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 21/12/2022 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 |
| Length of the financial year | 12 months | 12 months | 13 months |
| Filing date | 19/05/2026 | 08/05/2025 | 29/07/2024 |
| General meeting | 21/04/2026 | 15/04/2025 | 15/07/2024 |
| Currency of the financial year | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
3 filings with the NBB
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 3 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20251,3 k €↓
- 2024Annual accounts 20246,1 k €↑
- 2023Annual accounts 20232,4 k €
- 22/12/2022IncorporationPrivate limited company